Explore TMA's podcast library, featuring three programs that inform, inspire, and support Texas physicians and patients. Each podcast has its own distinct focus, including personal wellness, …

Thrombotic microangiopathies (TMA) are clinical syndromes defined by the presence of hemolytic anemia (destruction of red blood cells), low platelets, and organ damage due to the formation of …

Thrombotic microangiopathy (TMA) is a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury. [1] It may be seen in association with thrombocytopenia, anemia, …

Nov 28, 2025 · Thrombotic Microangiopathy (TMA) describes a group of serious disorders characterized by widespread damage to the body’s smallest blood vessels. This damage triggers the formation of …

Thrombotic microangiopathy (TMA) is a heterogenous group of rare disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia and end organ damage that can occur …

What is Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (often known simply as TMA) is a rare but serious medical disease. It is a pattern of damage that can occur in the smallest blood …

We’re excited to announce that registration is officially open for the 2026 TMA Distressed Investing Conference, the leading event for networking and dealmaking in turnaround, restructuring, and …

Thrombotic Microangiopathy (TMA) is a comprehensive term that describes syndromes with similar pathologic and clinical features. We use the term, "primary TMA syndromes," to describe the …

Learn about thrombotic microangiopathy (TMA), its causes, symptoms, diagnosis, and treatment options like eculizumab and plasma exchange. Manage TMA effectively with expert guidance.

Thrombotic microangiopathies (TMAs) are a group of potentially life-threatening conditions characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombi.